Last reviewed · How we verify

NCT06781320

Digital Occlusal Analysis and Enamel Wear Assessment in Temporomandibular Disorder Patients Treated with Fully Digital Versus Conventional Stabilization Splints

Not yet recruiting NA Last updated 17 January 2025
What this trial tests

NA trial testing stabilization splint in TMD in 20 participants. Not yet recruiting.

Timeline
26 January 2025
Primary endpoint
25 December 2025
17 July 2026

Quick facts

Lead sponsorMinia University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date26 January 2025
Primary completion25 December 2025
Estimated completion17 July 2026

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 18 to 40, any sex, with TMD or Temporomandibular Disorders (TMD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled research aimed to analyse the occlusion and assist the enamel wear before and after using of the stabilization splints produced by the conventional methods with the fully digitally fabricated stabilization splints. Research question: Will the fully digital stabilization splint offer significantly better occlusal equilibration and enamel wear compared to the conventional stabilization splint? the primary outcome will be Digital occlusal analysis, and secondary outcome will be enamel wear assessment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of stabilization splint

Trials testing the same drug.

Other recruiting trials for TMD

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06781320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing